ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Feb 19, 2015

SEC Form 3/A — Form 3/A

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-02-17

Reporting Person: Harel Ittai (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$4.342	2024-08-28	Common Stock (9857)		Direct

Footnotes

F1: These options are fully vested.